Axi-Cel: Clinical Trials

1 trial of Axi-Cel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Axi-Cel: new trials by email Literature Review of Axi-Cel trials Research Report on Axi-Cel

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Axicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma
Leukapheresis, Bridging Therapy, Lymphodepletion - B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent
Phase 2TerminatedUniversität Münster12025-03-132025-09-04

Sponsors

Universität Münster (1)

Countries

Germany (1)

Top investigators

Georg Lenz, Prof (1)